Volume 78, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The diagnosis of active infection in bancroftian filariasis continues to pose an important and continuously evolving challenge to filariasis-endemic countries and to health personnel. Sensitivity of the immunochromatographic card test (ICT) relative to detection of adult worms by ultrasound was evaluated in a retrospective study conducted in the Center for Teaching, Research and Tertiary Referral Hospital for bancroftian filariasis (Federal University of Pernambuco) in Recife, Brazil. The results showed that among 408 persons tested, the overall sensitivity of the ICT was 84.5% and varied from 52% to 100% when patients were grouped by different criteria (age, sex, presence or absence of living adult worms by ultrasound, microfilaremia status/density). The present study provides evidence that a negative antigen result should be interpreted cautiously and may help to explain the different sensitivities of the antigen test found by different investigators in settings with different transmission intensities.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Weil GJ, Liftis F, 1987. Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti. J Immunol 138 : 3035–3041. [Google Scholar]
  2. Weil GJ, Lammie PJ, Weiss N, 1997. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 13 : 401–404. [Google Scholar]
  3. Sunish IP, Rajendran R, Satyanarayana K, Munirathinam A, Gajanama A, 2001. Immunochromatographic test (ICT) for estimation of true prevalence of bancroftian filariasis in an endemic area in southern India. Trans R Soc Trop Med Hyg 95 : 607–609. [Google Scholar]
  4. Weil G, Ramzy RM, Chandrashekar T, Gad AM, Lowrie RC Jr, Faris R, 1996. Parasite antigenemia without microfilaremia in bancroftian filariasis. Am J Trop Med Hyg 55 : 333–337. [Google Scholar]
  5. Amaral F, Dreyer G, Figueredo-Silva J, Norões J, Cavalcanti A, Samico SF, Santos A, Coutinho A, 1994. Live adult worms detected by ultrasonography in human bancroftian filariasis. Am J Trop Med Hyg 50 : 753–757. [Google Scholar]
  6. Dreyer G, Figueredo-Silva J, Carvalho K, Amaral F, Ottesen EA, 2001. Lymphatic filariasis in children: adenopathy and its evolution in two young girls. Am J Trop Med Hyg 65 : 204–207. [Google Scholar]
  7. Dreyer G, Noroes J, Addiss D, Santos A, Medeiros Z, Figueredo-Silva J, 1999. Bancroftian filariasis in a paediatric population: an ultrasonographic study. Trans R Soc Trop Med Hyg 93 : 633–636. [Google Scholar]
  8. Nguyen NL, Plichart C, Esterre P, 1999. Assessment of immunochromatographic test for rapid lymphatic filariasis diagnosis. Parasite 6 : 355–358. [Google Scholar]
  9. Chandrasena TG, Premaratna R, Abeyewickrema W, de Silva NR, 2002. Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka. Trans R Soc Trop Med Hyg 96 : 60–63. [Google Scholar]
  10. Ramzy RM, Helmy H, Ei-Lethy AST, Kandil AM, Ahmed ES, Weil GJ, Faris R, 1999. Field evaluation of a rapid-format kit for the diagnosis of bancroftian filariasis in Egypt. East Mediterr Health J 5 : 880–887. [Google Scholar]
  11. Phantana S, Sensathein S, Songtrus J, Klagrathoke S, Phongnin K, 1999. ICT filariasis test: a new screening test for bancroftian filariasis. Southeast Asian J Trop Med Public Health 30 : 47–51. [Google Scholar]
  12. Pani SP, Hoti SL, Elango A, Yuvaraj J, Lall R, Ramaiah KD, 2000. Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India. Trop Med Int Health 5 : 359–363. [Google Scholar]
  13. Weil GJ, Lammie PJ, Richards FO Jr, Eberhard ML, 1991. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin. J Infect Dis 164 : 814–816. [Google Scholar]
  14. Nicolas L, Plichart C, Nguyen LN, Moulia-Pelat JP, 1997. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. J Infect Dis 175 : 489–492. [Google Scholar]
  15. Weil GJ, Sethumadhavan KVP, Santhanam S, Jain DC, Ghosh TK, 1988. Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis. Am J Trop Med Hyg 38 : 589–595. [Google Scholar]
  16. Freedman DO, Plier DA, de Almeida AB, de Oliveira AL, Miranda J, Braga C, 2001. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Trop Med Int Health 6 : 37–41. [Google Scholar]
  17. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Abdullah SM, Augustin DJ, Satyanarayana K, 2002. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia. Ann Trop Med Parasitol 96 : 595–602. [Google Scholar]
  18. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DC, Michalski ML, Dissanaike AS, 1998. Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bacroftian filariasis. Trans R Soc Trop Med Hyg 92 : 94–97. [Google Scholar]
  19. Schuetz A, Addiss DG, Eberhard ML, Lammie PJ, 2000. Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment. Am J Trop Med Hyg 62 : 502–503. [Google Scholar]
  20. Rawlins SC, Siung-Chang A, Baboolal S, Chadee DD, 2004. Evidence for the interruption of transmission of lymphatic filariasis among schoolchildren in Trinidad and Tobago. Trans R Soc Trop Med Hyg 98 : 473–477. [Google Scholar]
  21. World Health Organization, 1998. Report of a WHO Informal Consultation on Epidemiologic Approaches to Lymphatic Filariasis Elimination: Initial Assessment, Monitoring and Certification. Geneva: World Health Organization. WHO/FIL/ 99.195.
  22. World Health Organization, 2000. Preparing and Implementing a National Plan to Eliminate Lymphatic Filariasis. Geneva: World Health Organization. WHO/CDS/CPE/CEE/2000.16.
  23. Ramaiah KD, Vanamail P, Pani SP, Das PK, 2003. The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets. Ann Trop Med Parasitol 97 : 737–741. [Google Scholar]
  24. Rocha A, Addiss D, Ribeiro ME, Norões J, Baliza M, Medeiros Z, Dreyer G, 1996. Evaluation of the Og4C3 ELISA in Wuchereria bancrofti infection: infected persons with undetectable or ultra-low microfilarial densities. Trop Med Int Health 1 : 859–864. [Google Scholar]
  25. Ottesen EA, 1985. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis 7 : 341–356. [Google Scholar]
  26. Noroes J, Addiss D, Cedenho A, Figueredo-Silva J, Lima G, Dreyer G, 2003. Pathogenesis of filarial hydrocele: risk associated with intrascrotal nodules caused by death of adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg 97 : 561–566. [Google Scholar]
  27. Dreyer G, Santos A, Noroes J, Addiss D, 1999. Proposed panel of diagnostic criteria, including the use of ultrasound, to refine the concept of “endemic normals” in lymphatic filariasis. Trop Med Int Health 4 : 575–579. [Google Scholar]
  28. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z, Addiss D, 1997. Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 91 : 78–81. [Google Scholar]
  29. Rizzo JA, Belo C, Lins R, Dreyer G, 2007. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. Ann Trop Med Parasitol 101 : 423–433. [Google Scholar]
  30. Njenga SM, Wamae CN, 2001. Evaluation of ICT filariasis card test using whole capillary blood: comparison with Knott’s concentration and counting chamber methods. J Parasitol 87 : 1140–1143. [Google Scholar]
  31. Braga C, Dourado MI, Ximenes RA, Alves L, Brayner F, Rocha A, Field AN, 2003. Evaluation of the whole blood immunochromatographic test for rapid bancroftian filariasis diagnosis in the northeast of Brazil. Rev Inst Med Trop Sao Paulo 45 : 125–129. [Google Scholar]
  32. Das PK, Manoharan A, Srividya A, Grenfell BT, Bundy DA, Vanamail P, 1990. Frequency distribution of Wuchereria bancrofti microfilariae in human populations and its relationships with age and sex. Parasitology 101 : 429–434. [Google Scholar]
  33. Omar MS, Sheikha AK, Al-Amari OM, Abdalla SE, Musa RA, 2000. Field evaluation of two diagnostic antigen tests for Wuchereria bancrofti infection among indian expatriates in Saudi Arabia. Southeast Asian J Trop Med Public Health 31 : 415–418. [Google Scholar]
  34. McCarthy JS, Guinea A, Weil GJ, Ottesen EA, 1995. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. J Infect Dis 172 : 521–526. [Google Scholar]
  35. Turner PB, Copeman B, Gerisi D, Speare R, 1993. A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of bancroftian filariasis. Trop Med Parasitol 44 : 45–48. [Google Scholar]
  36. Faris R, Ramzy RM, Gad AM, Weil GJ, Buck AA, 1993. Community diagnosis of bancroftian filariasis. Trans R Soc Trop Med Hyg 87 : 659–661. [Google Scholar]
  37. Ramzy RM, Gad AM, Faris R, Weil GJ, 1991. Evaluation of a monoclonal-antibody based antigen assay for diagnosis of Wuchereria bancrofti infection in Egypt. Am J Trop Med Hyg 44 : 691–695. [Google Scholar]
  38. Chanteau S, Moulia-Pelat JP, Glaziou P, Nguyen NL, Luquiaud P, Plichart C, Martin PM, Cartel JL, 1994. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis 170 : 247–250. [Google Scholar]
  39. Plaisier AP, Cao WC, van Oortmarssen GJ, Habbema JD, 1999. Efficacy of ivermectin in the treatment of Wuchereria bancrofti infection: a model-based analysis of trials results. Parasitology 199 : 385–394. [Google Scholar]
  40. Chanteau S, Glaziou P, Plichart C, Luquiaud P, Moulia-Pelat JP, N’Guyen L, Cartel JL, 1995. Wuchereria bancrofti filariasis in French Polynesia: age-specific patterns of microfilaremia, circulating antigen, and specific IgG and IgG4 responses according to transmission level. Int J Parasitol 25 : 81–85. [Google Scholar]
  41. O’Connor FW, Golden R, 1930. The roentgen demonstration of calcified filaria bancrofti in human tissue. Am J Roentgenol Radium Ther 23 : 495–502. [Google Scholar]
  42. Wartman WB, 1944. Lesions of the lymphatic system in early filariasis. Am J Trop Med Hyg 24 : 299–313. [Google Scholar]
  43. Michael P, 1945. Filariasis: histophatologic study. US Nav Med Bull 45 : 225–236. [Google Scholar]
  44. Figueredo-Silva J, Noroes J, Cedenho A, Dreyer G, 2002. Histopathology of bancroftian filariasis revisited: the role of the adult worm in the lymphatic vessel disease. Ann Trop Med Parasitol 96 : 531–541. [Google Scholar]
  45. Steel C, Ottessen EA, Weller PF, Nutman TB, 2001. Worm burden and host responsiveness in Wuchereria bancrofti infection: use of antigen detection to refine earlier assessments from the south Pacific. Am J Trop Med Hyg 65 : 498–503. [Google Scholar]

Data & Media loading...

  • Received : 31 Aug 2007
  • Accepted : 25 Sep 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error